247 related articles for article (PubMed ID: 25186228)
1. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.
Schmitt J; Apfelbacher C; Spuls PI; Thomas KS; Simpson EL; Furue M; Chalmers J; Williams HC
J Invest Dermatol; 2015 Jan; 135(1):24-30. PubMed ID: 25186228
[TBL] [Abstract][Full Text] [Related]
2. The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap.
Leshem YA; Simpson EL; Apfelbacher C; Spuls PI; Thomas KS; Schmitt J; Howells L; Gerbens LAA; Jacobson ME; Katoh N; Williams HC
Br J Dermatol; 2023 Nov; 189(6):710-718. PubMed ID: 37548315
[TBL] [Abstract][Full Text] [Related]
3. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
[TBL] [Abstract][Full Text] [Related]
4. Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.
Jacobson ME; Thomas KS; Apfelbacher CJ; Leshem YA; Williams HC; Gerbens LAA; Spuls PI; Schmitt J; Howells L; Katoh N; Simpson EL;
Arch Dermatol Res; 2023 Nov; 315(9):2617-2622. PubMed ID: 37432466
[TBL] [Abstract][Full Text] [Related]
5. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
Schmitt J; Spuls P; Boers M; Thomas K; Chalmers J; Roekevisch E; Schram M; Allsopp R; Aoki V; Apfelbacher C; Bruijnzeel-Koomen C; Bruin-Weller M; Charman C; Cohen A; Dohil M; Flohr C; Furue M; Gieler U; Hooft L; Humphreys R; Ishii HA; Katayama I; Kouwenhoven W; Langan S; Lewis-Jones S; Merhand S; Murota H; Murrell DF; Nankervis H; Ohya Y; Oranje A; Otsuka H; Paul C; Rosenbluth Y; Saeki H; Schuttelaar ML; Stalder JF; Svensson A; Takaoka R; Wahlgren CF; Weidinger S; Wollenberg A; Williams H
Allergy; 2012 Sep; 67(9):1111-7. PubMed ID: 22844983
[TBL] [Abstract][Full Text] [Related]
6. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.
Chalmers J; Deckert S; Schmitt J;
Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):227-33. PubMed ID: 26153875
[TBL] [Abstract][Full Text] [Related]
7. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany.
Schmitt J; Williams H;
Br J Dermatol; 2010 Dec; 163(6):1166-8. PubMed ID: 21137114
[TBL] [Abstract][Full Text] [Related]
8. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
Leshem YA; Chalmers JR; Apfelbacher C; Furue M; Gerbens LAA; Prinsen CAC; Schmitt J; Spuls PI; Thomas KS; Williams HC; Simpson EL;
J Am Acad Dermatol; 2020 May; 82(5):1181-1186. PubMed ID: 31926221
[TBL] [Abstract][Full Text] [Related]
9. Core Outcome Sets Relevant to Maternity Service Users: A Scoping Review.
Slavin V; Creedy DK; Gamble J
J Midwifery Womens Health; 2021 Mar; 66(2):185-202. PubMed ID: 33565682
[TBL] [Abstract][Full Text] [Related]
10. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2020 Nov; ():. PubMed ID: 33179283
[TBL] [Abstract][Full Text] [Related]
11. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
Spuls PI; Gerbens LAA; Simpson E; Apfelbacher CJ; Chalmers JR; Thomas KS; Prinsen CAC; von Kobyletzki LB; Singh JA; Williams HC; Schmitt J;
Br J Dermatol; 2017 Apr; 176(4):979-984. PubMed ID: 27858989
[TBL] [Abstract][Full Text] [Related]
12. CONSIDER - Core Outcome Set in IAD Research: study protocol for establishing a core set of outcomes and measurements in incontinence-associated dermatitis research.
Van den Bussche K; De Meyer D; Van Damme N; Kottner J; Beeckman D
J Adv Nurs; 2017 Oct; 73(10):2473-2483. PubMed ID: 27682261
[TBL] [Abstract][Full Text] [Related]
13. Navigating the landscape of core outcome set development in dermatology.
Prinsen CAC; Spuls PI; Kottner J; Thomas KS; Apfelbacher C; Chalmers JR; Deckert S; Furue M; Gerbens L; Kirkham J; Simpson EL; Alam M; Balzer K; Beeckman D; Eleftheriadou V; Ezzedine K; Horbach SER; Ingram JR; Layton AM; Weller K; Wild T; Wolkerstorfer A; Williams HC; Schmitt J
J Am Acad Dermatol; 2019 Jul; 81(1):297-305. PubMed ID: 30878565
[TBL] [Abstract][Full Text] [Related]
14. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative.
Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW
Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353
[TBL] [Abstract][Full Text] [Related]
15. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
[TBL] [Abstract][Full Text] [Related]
16. Improvement was needed in the standards of development for cancer core outcome sets.
Gargon E; Williamson PR; Blazeby JM; Kirkham JJ
J Clin Epidemiol; 2019 Aug; 112():36-44. PubMed ID: 31009657
[TBL] [Abstract][Full Text] [Related]
17. Identifying common core outcome domains from core outcome sets of musculoskeletal conditions: protocol for a systematic review.
Sabet TS; Anderson DB; Stubbs PW; Buchbinder R; Terwee CB; Chiarotto A; Gagnier J; Verhagen AP
Syst Rev; 2022 Nov; 11(1):248. PubMed ID: 36403060
[TBL] [Abstract][Full Text] [Related]
18. Controversy and Debate Series on Core Outcome Sets. Paper 1: Improving the generalizability and credibility of core outcome sets (COS) by a large and international participation of diverse stakeholders.
Chevance A; Tran VT; Ravaud P
J Clin Epidemiol; 2020 Sep; 125():206-212.e1. PubMed ID: 31945480
[TBL] [Abstract][Full Text] [Related]
19. Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
Kottner J; Jacobi L; Hahnel E; Alam M; Balzer K; Beeckman D; Busard C; Chalmers J; Deckert S; Eleftheriadou V; Furlan K; Horbach SER; Kirkham J; Nast A; Spuls P; Thiboutot D; Thorlacius L; Weller K; Williams HC; Schmitt J;
Br J Dermatol; 2018 Apr; 178(4):e279-e285. PubMed ID: 29441525
[TBL] [Abstract][Full Text] [Related]
20. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process.
Schmitt J; Langan S; Stamm T; Williams HC;
J Invest Dermatol; 2011 Mar; 131(3):623-30. PubMed ID: 20944653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
